<p>Option Care Health（纳斯达克股票代码：OPCH - 获取免费报告）在周一发布的报告中被 Zacks Research 的股票分析师从 “持有” 评级下调至 “强烈卖出” 评级，Zacks.com 报道。</p>
<p>获取 <strong>Option Care Health</strong> 的提醒：</p>
<ul>
<li>Option Care Health 股票正在进行健康的回调</li>
</ul>
<p>其他几位股票研究分析师也对该公司发表了评论。Jefferies Financial Group 在 1 月 13 日的研究报告中重申了 “买入” 评级，并将 Option Care Health 的目标价设定为 37.00 美元。TD Cowen 在 5 月 1 日的研究报告中将 Option Care Health 的目标价从 37.00 美元下调至 23.00 美元，并对该股票设定了 “持有” 评级。摩根士丹利在 5 月 6 日的研究报告中将 Option Care Health 的目标价设定为 28.00 美元。Citizens Jmp 在 1 月 13 日的研究报告中重申了 “市场跑赢大盘” 评级，并将 Option Care Health 的目标价设定为 38.00 美元（上调自 36.00 美元）。最后，Barrington Research 在 5 月 1 日的研究报告中将 Option Care Health 的目标价从 42.00 美元下调至 32.00 美元，并对该股票设定了 “跑赢大盘” 评级。一位股票研究分析师给予该股票 “强烈买入” 评级，八位给予 “买入” 评级，三位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 31.25 美元。</p>
<p><strong>获取我们关于 Option Care Health 的最新股票报告</strong></p>
<h2>Option Care Health 股票下跌 1.2%</h2>
<p>周一，Option Care Health 股票开盘价为 19.59 美元。Option Care Health 的年低为 18.01 美元，年高为 36.80 美元。该公司的债务与股本比率为 0.85，流动比率为 1.64，速动比率为 1.07。该股票的 50 日移动平均线为 27.52 美元，200 日移动平均线为 30.43 美元。该公司的市值为 30.8 亿美元，市盈率为 15.19，PEG 比率为 1.10，贝塔值为 0.68。</p>
<p>Option Care Health（纳斯达克股票代码：OPCH - 获取免费报告）最后一次公布财报是在 4 月 30 日，报告显示该公司本季度每股收益为 0.40 美元，超出市场共识预期的 0.37 美元，超出幅度为 0.03 美元。Option Care Health 的股本回报率为 18.17%，净利润率为 3.64%。该公司本季度的收入为 13.5 亿美元，而分析师预期为 13.9 亿美元。在去年同期，该公司每股收益为 0.40 美元。与去年同期相比，该公司的季度收入增长了 1.3%。Option Care Health 已将其 2026 财年的指引设定为 1.820-1.920 每股收益。股票研究分析师预计 Option Care Health 在当前年度将发布 1.64 每股收益。</p>
<h2>Option Care Health 的内部交易</h2>
<p>在相关消息中，首席执行官 John Charles Rademacher 在 5 月 4 日的交易中购买了 12,500 股该股票。该股票的平均购买成本为每股 21.18 美元，总价值为 264,750.00 美元。完成购买后，首席执行官直接持有该公司 695,152 股股票，价值为 14,723,319.36 美元。这笔交易代表其持股比例增加了 1.83%。该购买在向证券交易委员会的法律文件中披露，可以通过此链接访问。此外，董事 Timothy P. Sullivan 在 5 月 7 日的交易中购买了 24,154 股该股票。该股票的平均购买成本为每股 20.69 美元，总价值为 499,746.26 美元。完成购买后，该董事持有 73,383 股公司的股票，价值约为 1,518,294.27 美元。这笔交易使其持股比例增加了 49.06%。有关此次购买的更多细节可在官方 SEC 披露中找到。在过去的九十天里，内部人士共购买了 73,264 股公司股票，价值为 1,548,316 美元。目前，1.70% 的股票由内部人士持有。</p>
<h2>Option Care Health 的机构交易</h2>
<p>机构投资者和对冲基金最近修改了对该股票的持有情况。V Square Quantitative Management LLC 在第四季度购买了 Option Care Health 的新股份，价值约为 25,000 美元。Cornerstone Planning Group LLC 在第三季度将其在 Option Care Health 的股份增加了 7,621.4%。Cornerstone Planning Group LLC 现在拥有该公司 1,081 股股票，价值 30,000 美元，此前在上个季度购买了 1,067 股。McIlrath &amp; Eck LLC 在第二季度购买了 Option Care Health 的新股份，价值约为 37,000 美元。Advisory Services Network LLC 在第三季度购买了 Option Care Health 的新股份，价值约为 35,000 美元。最后，Caitong International Asset Management Co. Ltd 在第三季度购买了 Option Care Health 的新股份，价值约为 38,000 美元。98.05% 的股票由对冲基金和其他机构投资者持有。</p>
<h2>Option Care Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Option Care Health（纳斯达克：OPCH）是美国领先的家庭和替代场所输液服务提供商。该公司专注于注射疗法的管理，包括抗生素、营养、补液、免疫球蛋白、疼痛管理和特殊药物。通过其全国性的输液药房和护理专业人员网络，Option Care Health 为管理复杂或慢性病的患者提供定制的护理计划和上门护理服务。</p>
<p>Option Care Health 的当前结构可追溯到 2021 年初与 BioScrip 合并的完成，结合了该行业中两家经验最丰富的家庭输液业务。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票，而不是 Option Care Health</li>
<li>海军催化剂点燃了 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河 Q1 业绩不佳而暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大幅上涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BDSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="650" height="330" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BDSA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 $1,000 在 Option Care Health 吗？</h2>
<p>在考虑 Option Care Health 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Option Care Health 并不在名单上。</p>
<p>虽然 Option Care Health 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得投资。</p>
<p>在这里查看这五只股票</p>

拜尔斯普保健

医疗业 ETF - SPDR

标普全球医疗股指数 ETF - iShares

标普医疗保健服务 ETF - SPDR

医疗业 ETF - Vanguard

美国医疗保健供应商 ETF - iShares

<p>Zacks Research 将 Option Care Health (NASDAQ:OPCH) 的评级从 “持有” 下调至 “强烈卖出”。其他分析师的看法各不相同，Jefferies 维持 “买入” 评级，目标价为 37 美元，而 TD Cowen 将目标价下调至 23 美元。该股开盘价为 19.59 美元，下跌 1.2%，市值为 30.8 亿美元。最近的内部购买包括首席执行官 John Rademacher 收购了 12,500 股。分析师预计 Option Care Health 本年度每股收益为 1.64 美元，普遍评级为 “适度买入”，平均目标价为 31.25 美元</p>

<p>Option Care Health (NASDAQ:OPCH - Get Free Report) was downgraded by stock analysts at Zacks Research from a &#34;hold&#34; rating to a &#34;strong sell&#34; rating in a report released on Monday,Zacks.com reports.</p>
<div class="lb-trans"><p>Option Care Health（纳斯达克股票代码：OPCH - 获取免费报告）在周一发布的报告中被 Zacks Research 的股票分析师从 “持有” 评级下调至 “强烈卖出” 评级，Zacks.com 报道。</p>
</div><p>Get <strong>Option Care Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Option Care Health</strong> 的提醒：</p>
</div><ul>
<li>Option Care Health Stock is Making a Healthy Pullback</li>
</ul>
<div class="lb-trans"><ul>
<li>Option Care Health 股票正在进行健康的回调</li>
</ul>
</div><p>Several other equities research analysts have also commented on the company. Jefferies Financial Group restated a &#34;buy&#34; rating and set a $37.00 target price on shares of Option Care Health in a research report on Tuesday, January 13th. TD Cowen cut their target price on Option Care Health from $37.00 to $23.00 and set a &#34;hold&#34; rating on the stock in a research report on Friday, May 1st. Morgan Stanley set a $28.00 target price on Option Care Health in a research report on Wednesday, May 6th. Citizens Jmp restated a &#34;market outperform&#34; rating and set a $38.00 target price (up from $36.00) on shares of Option Care Health in a research report on Tuesday, January 13th. Finally, Barrington Research dropped their price target on Option Care Health from $42.00 to $32.00 and set an &#34;outperform&#34; rating on the stock in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $31.25.</p>
<div class="lb-trans"><p>其他几位股票研究分析师也对该公司发表了评论。Jefferies Financial Group 在 1 月 13 日的研究报告中重申了 “买入” 评级，并将 Option Care Health 的目标价设定为 37.00 美元。TD Cowen 在 5 月 1 日的研究报告中将 Option Care Health 的目标价从 37.00 美元下调至 23.00 美元，并对该股票设定了 “持有” 评级。摩根士丹利在 5 月 6 日的研究报告中将 Option Care Health 的目标价设定为 28.00 美元。Citizens Jmp 在 1 月 13 日的研究报告中重申了 “市场跑赢大盘” 评级，并将 Option Care Health 的目标价设定为 38.00 美元（上调自 36.00 美元）。最后，Barrington Research 在 5 月 1 日的研究报告中将 Option Care Health 的目标价从 42.00 美元下调至 32.00 美元，并对该股票设定了 “跑赢大盘” 评级。一位股票研究分析师给予该股票 “强烈买入” 评级，八位给予 “买入” 评级，三位给予 “持有” 评级，一位给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，平均目标价为 31.25 美元。</p>
</div><p><strong>Get Our Latest Stock Report on Option Care Health</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Option Care Health 的最新股票报告</strong></p>
</div><h2>Option Care Health Stock Down 1.2%</h2>
<div class="lb-trans"><h2>Option Care Health 股票下跌 1.2%</h2>
</div><p>Shares of Option Care Health stock opened at $19.59 on Monday. Option Care Health has a one year low of $18.01 and a one year high of $36.80. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.64 and a quick ratio of 1.07. The stock's 50-day moving average is $27.52 and its 200 day moving average is $30.43. The firm has a market cap of $3.08 billion, a price-to-earnings ratio of 15.19, a PEG ratio of 1.10 and a beta of 0.68.</p>
<div class="lb-trans"><p>周一，Option Care Health 股票开盘价为 19.59 美元。Option Care Health 的年低为 18.01 美元，年高为 36.80 美元。该公司的债务与股本比率为 0.85，流动比率为 1.64，速动比率为 1.07。该股票的 50 日移动平均线为 27.52 美元，200 日移动平均线为 30.43 美元。该公司的市值为 30.8 亿美元，市盈率为 15.19，PEG 比率为 1.10，贝塔值为 0.68。</p>
</div><p>Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported $0.40 EPS for the quarter, beating the consensus estimate of $0.37 by $0.03. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.39 billion. During the same quarter in the prior year, the company earned $0.40 EPS. The firm's revenue for the quarter was up 1.3% compared to the same quarter last year. Option Care Health has set its FY 2026 guidance at 1.820-1.920 EPS. Equities research analysts anticipate that Option Care Health will post 1.64 EPS for the current year.</p>
<div class="lb-trans"><p>Option Care Health（纳斯达克股票代码：OPCH - 获取免费报告）最后一次公布财报是在 4 月 30 日，报告显示该公司本季度每股收益为 0.40 美元，超出市场共识预期的 0.37 美元，超出幅度为 0.03 美元。Option Care Health 的股本回报率为 18.17%，净利润率为 3.64%。该公司本季度的收入为 13.5 亿美元，而分析师预期为 13.9 亿美元。在去年同期，该公司每股收益为 0.40 美元。与去年同期相比，该公司的季度收入增长了 1.3%。Option Care Health 已将其 2026 财年的指引设定为 1.820-1.920 每股收益。股票研究分析师预计 Option Care Health 在当前年度将发布 1.64 每股收益。</p>
</div><h2>Insider Transactions at Option Care Health</h2>
<div class="lb-trans"><h2>Option Care Health 的内部交易</h2>
</div><p>In related news, CEO John Charles Rademacher acquired 12,500 shares of the stock in a transaction dated Monday, May 4th. The stock was purchased at an average cost of $21.18 per share, with a total value of $264,750.00. Following the completion of the purchase, the chief executive officer directly owned 695,152 shares in the company, valued at $14,723,319.36. This trade represents a 1.83% increase in their position. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which can be accessed through this hyperlink. Also, Director Timothy P. Sullivan acquired 24,154 shares of the stock in a transaction dated Thursday, May 7th. The stock was bought at an average cost of $20.69 per share, with a total value of $499,746.26. Following the completion of the purchase, the director owned 73,383 shares of the company's stock, valued at approximately $1,518,294.27. The trade was a 49.06% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders purchased a total of 73,264 shares of company stock valued at $1,548,316 over the last ninety days. 1.70% of the stock is currently owned by insiders.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 John Charles Rademacher 在 5 月 4 日的交易中购买了 12,500 股该股票。该股票的平均购买成本为每股 21.18 美元，总价值为 264,750.00 美元。完成购买后，首席执行官直接持有该公司 695,152 股股票，价值为 14,723,319.36 美元。这笔交易代表其持股比例增加了 1.83%。该购买在向证券交易委员会的法律文件中披露，可以通过此链接访问。此外，董事 Timothy P. Sullivan 在 5 月 7 日的交易中购买了 24,154 股该股票。该股票的平均购买成本为每股 20.69 美元，总价值为 499,746.26 美元。完成购买后，该董事持有 73,383 股公司的股票，价值约为 1,518,294.27 美元。这笔交易使其持股比例增加了 49.06%。有关此次购买的更多细节可在官方 SEC 披露中找到。在过去的九十天里，内部人士共购买了 73,264 股公司股票，价值为 1,548,316 美元。目前，1.70% 的股票由内部人士持有。</p>
</div><h2>Institutional Trading of Option Care Health</h2>
<div class="lb-trans"><h2>Option Care Health 的机构交易</h2>
</div><p>Institutional investors and hedge funds have recently modified their holdings of the stock. V Square Quantitative Management LLC purchased a new stake in shares of Option Care Health in the fourth quarter worth approximately $25,000. Cornerstone Planning Group LLC raised its stake in shares of Option Care Health by 7,621.4% in the third quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company's stock worth $30,000 after purchasing an additional 1,067 shares during the last quarter. McIlrath &amp; Eck LLC purchased a new stake in shares of Option Care Health in the second quarter worth approximately $37,000. Advisory Services Network LLC purchased a new stake in shares of Option Care Health in the third quarter worth approximately $35,000. Finally, Caitong International Asset Management Co. Ltd purchased a new stake in shares of Option Care Health in the third quarter worth approximately $38,000. 98.05% of the stock is owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>机构投资者和对冲基金最近修改了对该股票的持有情况。V Square Quantitative Management LLC 在第四季度购买了 Option Care Health 的新股份，价值约为 25,000 美元。Cornerstone Planning Group LLC 在第三季度将其在 Option Care Health 的股份增加了 7,621.4%。Cornerstone Planning Group LLC 现在拥有该公司 1,081 股股票，价值 30,000 美元，此前在上个季度购买了 1,067 股。McIlrath &amp; Eck LLC 在第二季度购买了 Option Care Health 的新股份，价值约为 37,000 美元。Advisory Services Network LLC 在第三季度购买了 Option Care Health 的新股份，价值约为 35,000 美元。最后，Caitong International Asset Management Co. Ltd 在第三季度购买了 Option Care Health 的新股份，价值约为 38,000 美元。98.05% 的股票由对冲基金和其他机构投资者持有。</p>
</div><h2>Option Care Health Company Profile</h2>
<div class="lb-trans"><h2>Option Care Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Option Care Health NASDAQ: OPCH is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.</p>
<div class="lb-trans"><p>Option Care Health（纳斯达克：OPCH）是美国领先的家庭和替代场所输液服务提供商。该公司专注于注射疗法的管理，包括抗生素、营养、补液、免疫球蛋白、疼痛管理和特殊药物。通过其全国性的输液药房和护理专业人员网络，Option Care Health 为管理复杂或慢性病的患者提供定制的护理计划和上门护理服务。</p>
</div><p>Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses.</p>
<div class="lb-trans"><p>Option Care Health 的当前结构可追溯到 2021 年初与 BioScrip 合并的完成，结合了该行业中两家经验最丰富的家庭输液业务。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than Option Care Health</li>
<li>Navy Catalyst Ignites Odysight’s Growth Engine</li>
<li>AST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival?</li>
<li>Axon Surged After Earnings and Is Still Down Over 50% From Highs</li>
<li>The Event That Could Redefine Apple’s Summer Rally</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，而不是 Option Care Health</li>
<li>海军催化剂点燃了 Odysight 的增长引擎</li>
<li>AST SpaceMobile 因银河 Q1 业绩不佳而暴跌：垂直整合能拯救这家 SpaceX 竞争对手吗？</li>
<li>Axon 在财报发布后大幅上涨，但仍比高点下跌超过 50%</li>
<li>可能重新定义苹果夏季反弹的事件</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9T1BDSA" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=OPCH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Option Care Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 $1,000 在 Option Care Health 吗？</h2>
</div><p>Before you consider Option Care Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Option Care Health 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Option Care Health 并不在名单上。</p>
</div><p>While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Option Care Health 目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得投资。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Option Care Health (NASDAQ:OPCH) Stock Rating Lowered by Zacks Research

Market Beat

Jefferies Financial

摩根士丹利

Citizens Financial

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SR I

CITIZENS FINANCIAL GROUP INC 5% DEP SHS EA REP 1/40TH NON CUM SER E

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SER H

拜尔斯普保健（NASDAQ 代码：OPCH）的股票评级被 Zacks Research 下调